Proactively preventing shortages: New FDA guidance spells out which drugs require risk management plans
As the majority of drug shortages are still associated with manufacturing-related quality issues, the FDA on Thursday published new draft guidance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
